With a little help from my f(X)riends!: The basis of Ad5-mediated transduction of the liver revealed

Molecular Therapy

Volumn 16, Issue 6, 2008, Pages 1004-1006

  Lowenstein, Pedro R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 10; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; INTEGRIN; PROTEOHEPARAN SULFATE; WARFARIN;

BINDING AFFINITY; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; HEPATITIS; INFLAMMATION; NONHUMAN; NOTE; PROTEIN BINDING; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS ENTRY; VIRUS INFECTION;

EID: 44349125838     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.80     Document Type: Note

References (18)

1. Alemany, R and Curiel, DT (2001). CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8 1347-1353.
2. Wickham, TJ (2003). Ligand-directed targeting of genes to the site of disease. Nat Med 9: 135-139.
3. Roelvink, PW, Mi Lee, G, Einfeld, DA, Kovesdi, I and Wickham, TJ (1999). Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286: 1568-1571.
4. Glasgow, JN, Everts, M and Curiel, DT (2006). Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13: 830-844.
5. Waehler, R, Russell, SJ and Curiel, DT (2007). Engineering targeted viral vectors for Gene Therapy. Nat Rev Genet 8: 573-587.
6. Thomas, CE, Edwards, P, Wickham, TJ, Castro, MG and Lowenstein, PR (2002). Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain infl ammation but is necessary to transduce specific neural cell types. J Virol 76 3452-3460.
7. Stone, D, Liu, Y, Li, ZY, Tuve, S, Strauss, R and Lieber, A (2007). Comparison of adenoviruses from species B, C, E, and F after intravenous delivery. Mol Ther 15: 2146-2153.
8. Kritz, AB, Nicol, CG, Dishart, KL, Nelson, R, Holbeck, S, Von Seggern, DJ et al. (2007). Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol Ther 15: 741-749.
9. Bayo-Puxan, N, Cascallo, M, Gros, A, Huch, M, Fillat, C and Alemany, R (2006). Role of the putative heparan sulfate glycosaminoglycan-binding site of the adeno-virus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J Gen Virol 87: 2487-2495.
10. Di Paolo, NC, Kalyuzhniy, O and Shayakhmetov, DM (2007). Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J Virol 81: 12249-12259.
11. Parker, AL, McVey, JH, Doctor, JH, Lopez-Franco, O, Waddington, SN, Havenga, MJ et al. (2007). Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J Virol 81: 3627-3631.
12. Parker, AL, Waddington, SN, Nicol, CG, Shayakhmetov, DM, Buckley, SM, Denby, L et al. (2006). Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108: 2554-2561.
13. Waddington, SN, Parker, AL, Havenga, M, Nicklin, SA, Buckley, SM, McVey, JH et al. (2007). Targeting of adenovirus serotype 5 (Ad5) and 5/ 47 pseudotyped vectors in vivo: Fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol 81: 9568-9571.
14. Shayakhmetov, DM, Gaggar, A, Ni, S, Li, ZY and Lieber, A (2005). Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79: 7478-7491.
15. Waddington, SN, McVey, JH, Bhella, D, Parker, AL, Barker, K, Atoda, H et al. (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
16. Kalyuzhniy, O, Di Paolo, NC, Silvestry, M, Hofherr, SE, Barry, MA, Stewart, PL et al. (2008). Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 105: 5483-5488.
17. Rux, J and Burnett, R (2000). Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol Ther 1, 18-30.
18. Venkateswarlu, D, Perera, L, Darden, T and Pedersen, L (2002). Structure and dynamics of zymogen human blood coagulation factor X. Biophys J 82, 1190-1206.